Deep Dive: Antibody Drug Conjugates (ADCs)

🎯 ADCs: Next in Cancer Therapy - From Ehrlich's 'magic bullet' to 14 approvals & 100+ in progress, explore how ADC technology targets #cancer , minimizing side effects & advancing precision oncology.

Read more: buff.ly/3W0hcsK

This analogy says it all 🙌

Thanks again to BIOS for featuring our founder and CEO, Charles Fisher.

Watch the full interview here: bit.ly/4b04bE0

#AI #DigitalTwins

Antibody drug conjugates (ADCs) are all the rage, for good reason.

They're generating stellar efficacy results in clinic, though they're not perfect.

I looked through 40+ ADC companies founded after 2010 to see what each was trying to improve on and with what new approach. ⬇️

BIOS Talent: Weekly Update 🌟

World’s 1st TechBio Job Board / Weekly Newsletter🧬

Unlock the Future of TechBio Careers with BIOS Talent and discover over 4000+ TechBio job openings.

Click below to learn more...
buff.ly/3TQjI2a

Deep Dive: High-Throughput Single-Cell Manipulation

🔬Single-cell tech boom to hit $5.5B! Sequencing innovations redefine precision medicine, unlocking drug discovery & diagnostics. Explore the future & investment prospects!

Read more: buff.ly/3vweCQE

the scientist that inspires me every day. it was wonderful to host Feng Zhang here at Arc Institute

I miss our 1am minipreps

Thanks to Drew Yashar and BIOS for interviewing our founder and CEO, Charles Fisher. Check it out! 🚀

BIOS Talent: Weekly Update 🌟

World’s 1st TechBio Job Board / Weekly Newsletter🧬

Unlock the Future of TechBio Careers with BIOS Talent and discover over 4000+ TechBio job openings.

Click below to learn more...
buff.ly/4ap04RQ